More importantly, BCR-mediated activation and proliferation of CLL cells was inhibited upon LAIR1 engagement only in those patients expressing LAIR1 at detectable levels [15]. The gene discussed is LAIR1; the disease is B-cell chronic lymphocytic leukemia.